• Penicillin G Sodium: Exposure, Evidence, and Assays

  2026-09-14

  Penicillin G Sodium is a natural penicillin antibiotic whose value depends on susceptibility, exposure schedule, and assay interpretation. This evidence-centered guide connects its cell-wall mechanism with orthogonal assay design while clarifying what canine tumor-cell research can—and cannot—tell us about antibacterial experiments.

• Angiotensin III: Designing Better RAAS Assays

  2026-09-14

  Angiotensin III is more than a downstream RAAS metabolite: it is a controllable perturbation for separating receptor, endocrine, and vascular responses. This guide translates recent binding-assay evidence into practical design, handling, and interpretation strategies for cardiovascular and neuroendocrine research.

• SB203580 Workflows for p38 MAPK Research

  2026-09-13

  Use SB203580 to separate p38-dependent stress signaling from the ERK mechanism highlighted in a recent vascular nanoplastic study. This practical guide covers potency-aware assay design, pathway-resolved readouts, solubility control, and applications spanning inflammation, neuroprotection studies, and multidrug resistance reversal.

• SD 169 and the Next Era of State-Aware p38 Biology

  2026-09-12

  SD 169 (indole-5-carboxamide) offers translational researchers a way to study p38α and p38β inhibition alongside kinase-state biology. This thought-leadership article connects ATP-competitive pathway control with activation-loop dephosphorylation, then translates that framework into experimental guidance for type 1 diabetes research, apoptosis assay design, and axonal regeneration research. It also defines the evidence boundaries around preclinical disease models and explains why SD 169 can function as more than a conventional p38 MAPK inhibitor.

• Fulvestrant (ICI 182,780): Reliable ER Assays

  2026-09-12

  A scenario-based laboratory guide to using Fulvestrant (ICI 182,780), SKU A1428, in ER-positive breast cancer viability, proliferation, apoptosis, and combination studies. It connects concentration selection, solvent handling, MDM2 protein degradation, and assay interpretation with practical evidence from product data and a published ER-mechanism study.

• Candida krusei Apoptosis in Bovine Mammary Cells

  2026-09-11

  Miao et al. showed that the yeast and hypha phases of Candida krusei both trigger apoptosis in bovine mammary epithelial cells, but through different dominant pathways. The yeast phase preferentially engaged mitochondrial injury, whereas the hypha phase was associated with death ligand/receptor signaling, with TLR2/ERK and JNK/ERK networks contributing to the response.

• Bufalin Workflows for TNBC Research

  2026-09-11

  Bufalin enables a practical bridge from cancer-cell phenotyping to target-engagement studies, with particular value in triple-negative breast cancer models. This guide combines solvent handling, STK33-focused assays, organoid translation, and troubleshooting for more interpretable preclinical results.

• Probenecid: From Transporter Biology to Translation

  2026-09-10

  Probenecid is more than an MRP inhibitor: it is a multidimensional mechanistic probe linking drug efflux, pannexin-1 signaling, lysosomal injury, and neuroinflammation. This article presents a translational framework for using 4-(dipropylsulfamoyl)benzoic acid to study multidrug resistance reversal in leukemia and neuroprotection in cerebral ischemia/reperfusion injury while controlling for pharmacological complexity.

• Atropo-Enantioselective Suzuki Synthesis of a Biaryl

  2026-09-10

  Herrbach and colleagues developed a catalytic asymmetric route to an axially chiral biaryl related to the antimitotic alkaloid rhazinilam. The study’s central advance was an intermolecular Suzuki coupling using chiral phosphine ligands, with binaphthyl ligand 7a furnishing the nonbridged precursor in up to 40% enantiomeric excess and establishing a useful strategy for biologically relevant atropisomers.

• Cyanine 5-dCTP for High-Contrast DNA Labeling

  2026-09-09

  Cyanine 5-dCTP adds a red-fluorescent readout to PCR, DNA fluorescent probe synthesis, and enzymatic oligonucleotide workflows. This guide connects Cy5 labeling with ordered DNA-framework strategies, emphasizing practical reaction design, controls, storage, and troubleshooting.

• PPM-18 for NF-κB/iNOS Workflows

  2026-09-09

  PPM-18 is a pathway-focused tool for separating NF-κB-driven iNOS expression from direct nitric oxide synthase inhibition. This guide shows how to build reproducible inflammation, immune-response, and sepsis research workflows while using the CCK-8s atrial study to improve time-resolved assay design.

• YM 58483 (BTP2): A Causal SOCE Assay Strategy

  2026-09-08

  YM 58483 (BTP2) is a powerful research tool for resolving how store-operated Ca2+ entry controls NFAT, IL-2, and fibrotic signaling. This article develops a causal assay framework that connects T-cell experiments with ORAI2-dependent salivary-gland fibrosis research while emphasizing interpretation, controls, and translational limits.

• Hepatic sEH–Nrf2 Axis in Osteoporosis

  2026-09-07

  The reference study identifies a liver–bone axis in which hepatic soluble epoxide hydrolase reduces circulating 14,15-EET, suppresses Nrf2-ARE antioxidant signaling, and promotes osteoclast differentiation. By combining patient samples, an ovariectomy-induced mouse model, liver-specific sEH knockdown, pharmacological inhibition, and transcriptomics, the work provides a mechanistic framework for studying redox imbalance in osteoporosis.

• LRPPRC–Dasatinib Dual OXPHOS Disruption

  2026-09-07

  The 2026 reference study identifies dasatinib as a synergistic partner for LRPPRC inhibition and shows that the combination suppresses oxidative phosphorylation through complementary effects on mitochondrial- and nuclear-encoded OXPHOS programs. Its screening and mechanistic framework supports biomarker-guided investigation of dual-genome metabolic targeting, while remaining limited to predominantly preclinical cell-model evidence.

• Cy3-UTP for Dynamic RNA Labeling and Kinetics

  2026-09-05

  Cy3-UTP enables covalent fluorescent labeling during transcription, connecting routine RNA production with imaging, interaction assays, and real-time conformational analysis. Its strongest use case is a controlled fluorescence workflow in which label density, position, and photostability are optimized rather than treated as fixed properties.

8619 records 1/575 page Next 12345 下5页 Last page